These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22799133)

  • 1. Reducing adverse drug events: a look at clinical pharmacy services.
    Smith CL
    J Ark Med Soc; 2012 Jun; 108(13):298-9. PubMed ID: 22799133
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrating health care: wave of the future.
    Connole P
    Provider; 2011 Jul; 37(7):20-2, 24-6, 29 passim. PubMed ID: 21812368
    [No Abstract]   [Full Text] [Related]  

  • 3. Integration demonstration. The CMS' latest pay-for-performance initiative will test the power of integrated delivery systems to alter doc practice patterns.
    Romano M
    Mod Healthc; 2005 Oct; 35(44):6-7, 16, 1. PubMed ID: 16300201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Never give in.
    Halamandaris VJ
    Caring; 1996 Oct; 15(10):84. PubMed ID: 10161688
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial management of health system pharmacy practice.
    Abramowitz PW
    Pharm Pract Manag Q; 1997 Jan; 16(4):79-83. PubMed ID: 10164163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare managed care and the need for quality measurement.
    Hanchak NA; Harmon-Weiss SR; McDermott PD; Hirsch A; Schlackman N
    Manag Care Q; 1996; 4(1):1-12. PubMed ID: 10154062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatry and primary care integration: challenges and opportunities.
    Sorel E; Everett A
    Int Rev Psychiatry; 2011; 23(1):28-30. PubMed ID: 21338295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersection of quality metrics and Medicare policy.
    Nau DP
    Ann Pharmacother; 2011 Dec; 45(12):1582-4. PubMed ID: 22045907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vast terra incognita of U.S. health care reform.
    Dentzer S
    Health Aff (Millwood); 2010 Jul; 29(7):1284. PubMed ID: 20606173
    [No Abstract]   [Full Text] [Related]  

  • 14. Telehealth and the national health information technology strategic framework.
    Speedie SM; Davies D
    J Telemed Telecare; 2006; 12 Suppl 2():S59-64. PubMed ID: 16989676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed health care.
    Curtiss FR
    Am J Hosp Pharm; 1989 Apr; 46(4):742-63. PubMed ID: 2719053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to integrate a hospice into your system.
    Orzechowski WJ
    Health Care Strateg Manage; 1996 Apr; 14(4):17-20. PubMed ID: 10155885
    [No Abstract]   [Full Text] [Related]  

  • 17. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
    Cheng C; Guglielmo BJ
    Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
    [No Abstract]   [Full Text] [Related]  

  • 18. Roundtable demonstration ... review of care given in private physician offices to Medicare beneficiaries.
    Palmer RH
    Med Care; 1995 Jan; 33(1 Suppl):JS41-4; discussion JS44-7. PubMed ID: 7823658
    [No Abstract]   [Full Text] [Related]  

  • 19. The Health Care Quality Improvement Program: the WVMI returns to its founding mission.
    Weeks HS
    W V Med J; 1994 Apr; 90(4):138-9. PubMed ID: 8009870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for self-reported adverse drug events among Medicare enrollees.
    Oladimeji O; Farris KB; Urmie JG; Doucette WR
    Ann Pharmacother; 2008 Jan; 42(1):53-61. PubMed ID: 18029427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.